Org.nr 985 889 635 2010 → 2011 Year-over-year analysis

LYTIX BIOPHARMA ASA: årsregnskap 2011 vs 2010

Mixed movements in the accounts

approved 2012-05-10; registry 2012-06-23; journal 2012 451095

Summary

What changed

Comparing Årsregnskap 2011 with 2010 for LYTIX BIOPHARMA ASA. Revenue 0 NOK → 53.9k NOK. Equity 79.59m NOK → 40.33m NOK.

On the constructive side: revenue rose; operating result improved; cash rose. Pressures included: equity eroded.

Also worth watching: paid-in equity reduced. All figures are taken from the published annual accounts for LYTIX BIOPHARMA ASA.

At a glance

Revenue

0 NOK 53.9k NOK

—

Operating result

-41.87m NOK -41.66m NOK

+0.5%

Equity

79.59m NOK 40.33m NOK

-49.3%

Cash

35.74m NOK 43.45m NOK

+21.6%

Total assets

91.12m NOK 51.50m NOK

-43.5%

↑
Revenue rose

Operating income / revenue moved from 0 NOK to 53.9k NOK. Calculated
↑
Operating result improved

Operating result -41.87m NOK → -41.66m NOK. Calculated
↑
Cash rose

Bank deposits 35.74m NOK → 43.45m NOK (+21.6% YoY). Calculated

↓
Equity eroded

Book equity 79.59m NOK → 40.33m NOK (equity ratio 87.3% → 78.3%). Calculated

·
Paid-in equity reduced

Paid-in equity fell 79.59m NOK → 40.33m NOK — check capital reduction, conversion, or reclassification. Interpretation